Mannkind (MNKD) Capital Expenditures Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.84% |
| Dec 31, 2025 | -19.28% |
| Sep 30, 2025 | -175.08% |
| Jun 30, 2025 | 33.04% |
| Mar 31, 2025 | 59.47% |
| Dec 31, 2024 | 28.29% |
| Sep 30, 2024 | -46.00% |
| Jun 30, 2024 | 48.11% |
| Mar 31, 2024 | 44.02% |
| Mar 31, 2021 | -3.13% |
| Dec 31, 2020 | 9.48% |
| Sep 30, 2020 | -68.21% |
| Jun 30, 2020 | -43.20% |
| Mar 31, 2020 | -62.30% |
| Dec 31, 2019 | -13.80% |
| Sep 30, 2019 | -15.57% |
| Jun 30, 2019 | -42.46% |
| Mar 31, 2019 | -28.19% |
| Mar 31, 2016 | -10.51% |
| Dec 31, 2015 | -39.61% |
| Sep 30, 2015 | -4.55% |